Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1590/S0104-59702016000100001 | DOI Listing |
BMC Cancer
January 2025
Department of Thoracic Surgery, the Second Hospital of Jilin University, Changchun, China.
Objective: The efficacy and safety of transcervical inflatable mediastinoscopic esophagectomy (TIME) in the treatment of esophageal cancer are unclear. The objective of this meta-analysis was to evaluate the efficacy and safety of TIME treatment for esophageal cancer and to compare it with thoracoscopic assisted minimally invasive esophagectomy (TAMIE) for the treatment of esophageal cancer.
Methods: A literature search was performed using PubMed, Embase, and the Cochrane Library to retrieve articles published up to January 2024 to comparatively assess studies of TIME and TAMIE.
Cell Stem Cell
January 2025
Bellingham, USA. Electronic address:
Editors' note: The Ogawa-Yamanaka Stem Cell Prize recognizes groundbreaking work in translational regenerative medicine using reprogrammed cells. The prize is supported by Gladstone Institutes, in partnership with Cell Press. Winner of the 2024 Ogawa-Yamanaka Stem Cell Prize Rusty Gage made landmark discoveries that fundamentally shifted the field of neuroscience.
View Article and Find Full Text PDFEur Rev Med Pharmacol Sci
December 2024
Institute of Primary Care, University of Zurich, Zurich, Switzerland.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!